A case of multi-agent drug resistant choriocarcinoma treated with Pembrolizumab
Jennifer A. Goldfarb, Giorgia Dinoi, Andrea Mariani, Carrie Langstraat
Abstract
•High-risk multi-agent drug resistant GTN is a life threatening disease.•Majority of choriocarcinomas show intense PD-L1 immunoreactivity.•Pembrolizumab increases antitumor activity.•Effectiveness of Pembrolizumab in treating patients with high-risk multi-agent drug resistant GTN.
Topics & Concepts
PembrolizumabMedicineDrugChoriocarcinomaOncologyInternal medicinePharmacologyCancerImmunotherapyGestational Trophoblastic Disease StudiesLung Cancer Research StudiesEpigenetics and DNA Methylation